EPISODE · Jan 4, 2024 · 8 MIN
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.
from Answers from the Lab · host Mayo Clinic Laboratories
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.Show notes(00:31)Could you provide us a little bit about your background? (01:20)Could you give us a brief overview of this assay? (02:45)What patients should have this test and when should it be performed? (04:25)Could you talk a little bit about alternative test options and how they compare to our ceramides test? (05:58)Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?
What this episode covers
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.Show notes(00:31)Could you provide us a little bit about your background? (01:20)Could you give us a brief overview of this assay? (02:45)What patients should have this test and when should it be performed? (04:25)Could you talk a little bit about alternative test options and how they compare to our ceramides test? (05:58)Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?
NOW PLAYING
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m